Navigation Links
/C O R R E C T I O N -- Agendia B.V./
Date:6/26/2009

ssay is always clinically useful and indicates whether a patient is at low or high risk for metastasis and the resulting clarity is vital in helping physicians personalize treatment options.

"St. Gallen's guideline inclusion is a key step in further establishing MammaPrint as a standard of care. It also supports our commitment to upholding rigorous standards of quality and efficacy," said Dr. Bernhard Sixt, Agendia's President and Chief Executive Officer. "With MammaPrint we aim to provide breast cancer patients and their physicians with definitive answers to crucial treatment questions."

In addition to MammaPrint, the company also offers TargetPrint to further improve breast cancer treatment options. TargetPrint quantitatively determines the gene expression levels of HER2neu, estrogen and progesterone receptors. Ongoing research and development efforts continue to augment Agendia's ability to accurately predict breast cancer recurrence, and help physicians tailor individual treatment plans to their patients.

    For online access to the Annals of Oncology:
http://annonc.oxfordjournals.org/cgi/content/full/mdp322v1

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of oncology and was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based i
'/>"/>

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
2. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
3. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
4. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
5. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
6. Agendia Launches TargetPrint(R) for Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Wound Management Technologies, Inc. ... provider of specialty medical products, announced today ... moving toward productization of its patented orthopedic ... anticipates products to be introduced in Q3 ... be a multi-billion dollar international market. ,, ...
(Date:12/16/2009)... (OTC Bulletin Board: HEWA) an online U.S. mail-order pharmacy, ... per annum short term debt financing. The structure ... $500,000, with accrued interest and principal repayable in one ... and principal repayable in one year from its funding, ... any calendar month prior to December 15, 2010. ...
(Date:12/16/2009)... -- International, well-known,scientific experts were surprised ... mg/day),data presented as "extremely promising."[1] More ... clinicians critically reviewed these data.,These experts ... lipid-modifying,treatments, fenofibrate and bezafibrate, in treating ... patients with metabolic syndrome,and type 2 ...
Breaking Medicine Technology:Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 4861 1Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 4861 2Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 4861 3Severe breathing disorders during sleep are associated with an increased risk of dying 9606 1Severe breathing disorders during sleep are associated with an increased risk of dying 9606 2Disney Donates 24100 000 to Red Cross Catastrophic Disaster Planning 54690 1Disney Donates 24100 000 to Red Cross Catastrophic Disaster Planning 54690 2
... Dr. Gregory Ellison, Director of Advanced Medical Center, Licensed to ... ... a critical crisis,of methamphetamine use, Dr. Gregory Ellison, Director of Advanced ... high success rates and is performed on an out-patient (versus,in-patient) basis ...
... Extensive Data to be Presented at the Upcoming ... Further to the,press release published on 9 April, ... elements of the clinical programme with,intravenous iclaprim in ... on ASSIST-1 has been presented at last year,s ...
Other Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
(Date:12/16/2009)... Access to Quality, Cost-Effective Care , ... Washington, D.C. ... debated the best ways to rein in runaway costs while providing ... important part of the ongoing discussion includes how to ensure patients ... doctors of medicine (MDs) or osteopathy (DOs). In both the ...
(Date:12/16/2009)... and Paper technology and the provider of the optimal paper-based ... is ranked among the Fastest Growing Technology Companies on the ... ... (PRWEB) December 16, 2009 -- Kayentis ... and management of handwritten data. Kayentis targets the Healthcare and ...
(Date:12/16/2009)... Age should not be determining factor for use, expert ... people with heart failure are much less likely to ... a new study. , The study included 4,685 people, ... device and had a left ventricular fraction (a measure ... less. , During a three-year period, those who were ...
(Date:12/16/2009)... Dec. 16 Shoppers like knowing if ... or Argentina. But grocers have found it burdensome ... (COOL) laws requiring them to provide the information ... at easyCOOLnow.com for easily making grocery ... include provisions that require retailers of unprocessed fruits, ...
(Date:12/16/2009)... software program developed by CareRise will reduce the time ... staffing needs as it relates to the patient population. ... to calculate their mandatory nurse-to-patient staffing needs, comply with ... report as to how it affects their bottom line. ... in the healthcare industry, has been allowed a United ...
Breaking Medicine News(10 mins):Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News:Implanted Defibrillator Might Extend Life 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2
... Plastics, Inc.,(OTC Bulletin Board: ECOO.OB) ("ECO2" or the ... way plastics are recycled, today,announced that initial test ... produce PET plastic flake that is suitably,pure for ... "Based upon the initial data and analysis performed ...
... Scientific,Corporation (NYSE: BSX ) is scheduled to ... is being held December 4-5 in New York,City., ... a 30-minute,presentation on Wednesday, December 5, beginning at ... Mr. LaViolette,s remarks will be available to all,interested ...
... 28 Martek Biosciences,announced today that life,sDHA(TM), its ... for brain, eye and heart health, is now,available ... Line. The,products include hamburgers, schnitzel, and cordon bleu, ... serving of Martek,s life,sDHA. Based in The,Netherlands, Dalco ...
... might also aid patients with hepatitis liver disease, study ... An experimental drug can boost the number of ... dangerous deficiency of these cells, researchers report. , The ... patients with the autoimmune disorder idiopathic thrombocytopenic purpura (ITP) ...
... Jeffersons Kimmel Cancer Center in Philadelphia have used ... breast tumors in laboratory animals, marking the first ... outside the body. This technology might someday help ... to find cancerous breast tumors as early as ...
... Empower Public Relations announces,their representation of top plastic ... Sam Chapman says, "Dr. Wiener is one of,the best ... to represent,this outstanding surgeon and to help him continue ... ABOUT DR. GREGORY WIENER:, Dr. Greg Wiener M.D. ...
Other Medicine News:Health News:ECO2 Plastics to File for FDA Approval for Food-Contact Applications 2Health News:ECO2 Plastics to File for FDA Approval for Food-Contact Applications 3Health News:Boston Scientific to Participate in BMO Capital Markets Healthcare Conference 2Health News:Martek's life'sDHA(TM) Featured in Dalco Foods Wellness Line Meat Products 2Health News:Martek's life'sDHA(TM) Featured in Dalco Foods Wellness Line Meat Products 3Health News:Drug May Help Reverse Clotting Deficiency 2Health News:Drug May Help Reverse Clotting Deficiency 3Health News:Jefferson scientists see breast cancer gene activity from outside the body 2
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 12 OD...
Medicine Products: